Acorda Therapeutics’ (ACOR) CEO Ron Cohen on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Ron Cohen Thanks, Jeff. Good morning, everyone. On today’s call I’ll provide an update on AMPYRA and our product development programs, and Mike will then review the Q1 financials with you. And after that, … more

View todays social media effects on ACOR

View the latest stocks trending across Twitter. Click to view dashboard

See who Acorda is hiring next, click here to view